Ultibro Breezhaler: Uses, Side Effects, Benefits/Risks - Drugs.com
Ultibro Breezhaler is a medicine that contains two active substances, indacaterol (85 micrograms) and glycopyrronium (43 micrograms). It is used as maintenance (regular) treatment to relieve …
Ultibro Breezhaler 並非用於氣管痙攣急性症狀發生時的治療。 過敏 Ultibro Breezhaler 所含成分indacaterol 或glycopyrronium，曾有報告在給藥後發生立即性過敏反應。若有過敏反
诺华慢阻肺新药在欧盟及日本获批 - 丁香园
2013年10月1日 · 诺华公司宣布，欧盟委员会已批准其每日1次Ultibro® Breezhaler® (茚达特罗/格隆溴铵)用于慢性阻塞性肺病（慢阻肺，COPD）成人患者维持治疗，用于缓解慢阻 …
Ultibro Breezhaler - European Medicines Agency (EMA)
Ultibro Breezhaler is a medicine that contains two active substances, indacaterol (85 micrograms) and glycopyrronium (43 micrograms). It is used as maintenance (regular) treatment to relieve …
Indacaterol/glycopyrronium bromide - Wikipedia
Indacaterol/glycopyrronium bromide, sold under the brand name Ultibro Breezhaler among others, is a fixed-dose combination medication for inhalation consisting of the following two active …
Ultibro Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). The recommended dose is …
Ultibro inhalation Capsules 14×110mcg/50mcg（格隆溴铵/茚达 …
Ultibro吸入性胶囊是实验性药物QVA149的商品名，通过Breezhaler单剂量干粉吸入器给药。 药效分类名称. 它是白色粉末。 易溶于水，微溶于乙醇（99.5）。 它是白色至浅黄色白色或浅灰色 …
Ultibro Breezhaler wird zur dauerhaften Behandlung Ihrer COPD angewendet. Verwen- den Sie dieses Arzneimittel nicht, um plötzliche Anfälle von Kurzatmigkeit oder pfei-
诺华Ultibro在COPD对照试验中优于舒利迭 - 丁香园
诺华正将Ultibro定位为一款符合慢性阻塞性肺疾病全球倡议(GOLD)指南的不含糖皮质激素的舒利迭替代产品，GOLD指南正试图降低吸入型类固醇药物的长期应用。
Ultibro Breezhaler - Novartis Europharm Limited - 药物在线
Ultibro Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).